Ruth Madlener
Angestellt, Director Manufacturing Tech. Sciences, Process Innovation, Takeda Pharmaceutical
Vienna, Österreich
Werdegang
Berufserfahrung von Ruth Madlener
Bis heute 2 Jahre und 11 Monate, seit Aug. 2021
Director Manufacturing Tech. Sciences, Process Innovation
Takeda Pharmaceutical
Responsible key function for the devolpment of validation strategies and execution thereof within design projects.
3 Jahre und 2 Monate, Jan. 2017 - Feb. 2020
Customer Project Manager, Expert process implementation and development
Rentschler Fill Solutions GmbH
Responsible for tech transfer, process characterisation, implementation and development, validation and market authorisation for fill and finish processes.
1 Jahr und 8 Monate, Mai 2015 - Dez. 2016
Supervisor - Process Science Plasma, Process Science
Baxalta
Process development, product support
2 Jahre, Mai 2013 - Apr. 2015
Supervisor R&D
Baxter Healthcare
Plasma Product Development / Product Support - Process development suitable for large scale manufacturing for novel plasma products
3 Jahre und 9 Monate, Sep. 2009 - Mai 2013
Sr Research Associate
Baxter Healthcare
Plasma Product Development / Product Support - Process development suitable for large scale manufacturing for novel plasma products
9 Monate, Okt. 2008 - Juni 2009
Research Associate
Universidad del país vasco (UPV/EHU)
Novel fungicide development against Candida spp. causing Candidiasis in immunosuppressed patients
1 Jahr und 7 Monate, März 2007 - Sep. 2008
Research Associate
Baxter Healthcare
Protein Modification of plasma and recombinant proteins
9 Monate, Okt. 2005 - Juni 2006
Diplomand
Department for Agrobiotechnology, IFA Tulln
Genetic marker selection in plants (Cucurbita spp.)
Ausbildung von Ruth Madlener
4 Jahre, Jan. 2010 - Dez. 2013
Pharmacology
Medical University of Vienna
Training in pre-Clinical and Clinical Study Design, Pharmacology and Pharmacoepidemiology, Process Development for Plasmatic Proteins, Drug Design, Formulation Studies
11 Monate, Sep. 2008 - Juli 2009
Master in Molecular Biology and Biomedicine
University of the Basque Country
Novel fungicide development against Candida spp. causing Candidiasis in immunosuppressed patients
3 Jahre und 10 Monate, Sep. 2002 - Juni 2006
Biotechnological Products Process Engineering
FH Wiener Neustadt
4 Jahre und 10 Monate, Sep. 1996 - Juni 2001
Commercial Academy
Sprachen
Deutsch
Muttersprache
Französisch
Gut
Spanisch
Fließend
Englisch
Fließend